Condition

Monoclonal Gammopathy of Renal Significance (3)

Multiple Myeloma (1)

Overall Status

Recruiting (2)

Unknown status (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Academia Nacional de Medicina (1)

Memorial Sloan Kettering Cancer Center (1)

University of Milano Bicocca (1)

Collaborator

Janssen Pharmaceuticals (1)

Intervention

bortezomib (1)

cyclophosphamide (1)

daratumumab (1)

dexamethasone (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (3)

Study Type

Interventional (1)

Observational (1)

Observational [Patient Registry] (1)

monoclonal gammopathy of renal significance

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Multiple Myeloma, Monoclonal Gammopathy of Renal Significance Trial in United States (Cyclophosphamide, Bortezomib,

Recruiting

Multiple Myeloma
Monoclonal Gammopathy of Renal Significance

Cyclophosphamide
+3 more

Basking Ridge, New Jersey
+6 more

Oct 16, 2023

Multicenter Case Series

Recruiting

Monoclonal Gammopathy of Renal Significance

San Fermo Della Battaglia, Como, Italy
+7 more

Jan 23, 2023

Monoclonal Gammopathy of Renal Significance Trial in Buenos Aires

Unknown status

Monoclonal Gammopathy of Renal Significance

Buenos Aires, Argentina

Academia Nacional de Medicina

Feb 23, 2019